Cell Therapy Clinical Trial Services Market Trends

The rise in the prevalence of chronic and genetic diseases has sparked a corresponding increase in the demand for cell therapy. Also, the increase in the number of research & development activities in the field of cell therapy has increased the demand for clinical trial services that is anticipated to boost the growth of the market.

• For instance, as per the report published in January 2024 reported that, the biopharma industry has its largest and most diverse clinical pipeline in the last few years. The total number of distinct drugs in development grew from 3,200 in 2012 to 6,100 in 2022. This pipeline is increasingly diverse with 14% of assets use modalities validated over the past five years (predominantly various forms of cell and gene therapy).
  
• Thus, the escalating prevalence of chronic and genetic diseases and rapid increase in R&D activities by biopharma industry for the development of advanced cell therapy products increases the demand for cell therapy clinical trial services that will boost the growth of the market.